Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography

Journal Article · · JAMA, J. Am. Med. Assoc.; (United States)

In vivo imaging of muscarinic acetylcholine receptor binding function in a patient with Alzheimer's disease, using single-photon emission computed tomography and iodine ST-labeled 3-quinuclidinyl-4-iodobenzilate ( STI-QNB), and perfusion imaging using STI-N-isopropyl p-iodoamphetamine are described. A profound decrease in perfusion to the posterior temporal and parietal cortex and a more uniform uptake of STI-QNB throughout the cerebral cortex were observed. The STI-QNB activity ratio was reduced compared with that of a normal age-matched subject, suggesting a moderate impairment in muscarinic receptor binding function in Alzheimer's disease. Furthermore, and more importantly, our study demonstrates that images of in vivo receptor binding can be obtained easily and nontraumatically using STI-QNB and single-photon emission computed tomography.

Research Organization:
Brigham and Women's Hospital, Boston, MA
OSTI ID:
6234660
Journal Information:
JAMA, J. Am. Med. Assoc.; (United States), Journal Name: JAMA, J. Am. Med. Assoc.; (United States) Vol. 21; ISSN JAMAA
Country of Publication:
United States
Language:
English